skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Antineoplastic Agents remover autor: Li, Jing remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical efficacy and survival analysis of apatinib combined with docetaxel in advanced esophageal cancer
Clinical efficacy and survival analysis of apatinib combined with docetaxel in advanced esophageal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical efficacy and survival analysis of apatinib combined with docetaxel in advanced esophageal cancer

Li, Jing ; Jia, Yongxu ; Gao, Yaping ; Chang, Zhiwei ; Han, Huiqiong ; Yan, Jie ; Qin, Yanru

OncoTargets and therapy, 2019-04, Vol.12, p.2577-2583 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
2
Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway
Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway

Ji, Feng ; Zhang, Fan ; Zhang, Miaomiao ; Long, Kaili ; Xia, Mingyue ; Lu, Fei ; Li, Enjie ; Chen, Jiannan ; Li, Jun ; Chen, Zhengliang ; Jing, Li ; Jia, Shaochang ; Yang, Rong ; Hu, Zhigang ; Guo, Zhigang

Journal of hematology and oncology, 2021-09, Vol.14 (1), p.1-152, Article 152 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Lnc-RP11-536 K7.3/SOX2/HIF-1[alpha] signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
Lnc-RP11-536 K7.3/SOX2/HIF-1[alpha] signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lnc-RP11-536 K7.3/SOX2/HIF-1[alpha] signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids

Li, Qingguo ; Sun, Huizhen ; Luo, Dakui ; Gan, Lu ; Mo, Shaobo ; Dai, Weixing ; Liang, Lei ; Yang, Yufei ; Xu, Midie ; Li, Jing ; Zheng, Peiyong ; Li, Xinxiang ; Li, Yan ; Wang, Ziliang

Journal of experimental & clinical cancer research, 2021-11, Vol.40 (1) [Periódico revisado por pares]

BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study
Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study

Feng, Feiling ; Cheng, Qingbao ; Zhang, Dadong ; Li, Bin ; Qin, Hao ; Xu, Chang ; Han, Miao ; Yu, Yong ; Li, Zhizhen ; Li, Jing-Yu ; Qiu, Zhiquan ; Xiong, Lei ; Liu, Chen ; Li, Fugen ; Yi, Bin ; Jiang, Xiaoqing

Oncology reports, 2020-04, Vol.43 (4), p.1089-1102

Greece: Spandidos Publications

Texto completo disponível

Citações Citado por
5
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

Sun, Jing ; Cai, Xin ; Yung, Mingo Mh ; Zhou, Wei ; Li, Jing ; Zhang, Yi ; Li, Zhuqing ; Liu, Stephanie S ; Cheung, Annie N Y ; Ngan, Hextan Y S ; Li, Yiliang ; Dai, Zhijun ; Kai, Yan ; Tzatsos, Alexandros ; Peng, Weiqun ; Chan, David W ; Zhu, Wenge

Oncogene, 2019-01, Vol.38 (4), p.564-580 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway
Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway
Material Type:
Artigo 		Adicionar ao Meu Espaço

Natural Compounds, Optimal Combination of Brusatol and Polydatin Promote Anti-Tumor Effect in Breast Cancer by Targeting Nrf2 Signaling Pathway

Li, Jing ; Zhang, Jianchao ; Zhu, Yan ; Afolabi, Lukman O ; Chen, Liang ; Feng, Xuesong

International journal of molecular sciences, 2023-05, Vol.24 (9), p.8265 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
7
Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses
Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses

Wang, Li-Xin ; Mei, Zhen-Yang ; Zhou, Ji-Hao ; Yao, Yu-Shi ; Li, Yong-Hui ; Xu, Yi-Han ; Li, Jing-Xin ; Gao, Xiao-Ning ; Zhou, Min-Hang ; Jiang, Meng-Meng ; Gao, Li ; Ding, Yi ; Lu, Xue-Chun ; Shi, Jin-Long ; Luo, Xu-Feng ; Wang, Jia ; Wang, Li-Li ; Qu, Chunfeng ; Bai, Xue-Feng ; Yu, Li Mattei, Fabrizio

PloS one, 2013-05, Vol.8 (5), p.e62924 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
8
Cabozantinib exposure–response analysis for the phase 3 CheckMate 9ER trial of nivolumab plus cabozantinib versus sunitinib in first-line advanced renal cell carcinoma
Cabozantinib exposure–response analysis for the phase 3 CheckMate 9ER trial of nivolumab plus cabozantinib versus sunitinib in first-line advanced renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cabozantinib exposure–response analysis for the phase 3 CheckMate 9ER trial of nivolumab plus cabozantinib versus sunitinib in first-line advanced renal cell carcinoma

Tran, Benjamin Duy ; Li, Jing ; Ly, Neang ; Faggioni, Raffaella ; Roskos, Lorin

Cancer chemotherapy and pharmacology, 2023-02, Vol.91 (2), p.179-189 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients

Wang, Wu-Yun ; Wu, Miao-Fang ; Wu, Dong-Bing ; Wang, Li-Juan ; Li, Hui ; Lin, Zhong-Qiu ; Li, Jing

Journal of ovarian research, 2021-01, Vol.14 (1), p.9-9, Article 9 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer

Li, Jing ; Li, Ya ; Wang, Huafeng ; Shen, Lifei ; Wang, Qun ; Shao, Siqi ; Shen, Yuhong ; Xu, Haoping ; Liu, Hua ; Cai, Rong ; Feng, Weiwei

BMC cancer, 2023-01, Vol.23 (1), p.51-51, Article 51 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (44)
  2. Revistas revisadas por pares (43)

Data de Publicação 

De até
Refinar
  1. Antes de2006  (3)
  2. 2006Até2009  (7)
  3. 2010Até2012  (5)
  4. 2013Até2018  (12)
  5. Após 2018  (20)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.